1. 1) Ministry of Health: Health Japan 21 (cardiovascular disease). (accessed 2021.8.21) 厚生労働省: 健康日本 21(循環器病).(参照 2021.8.21) https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kenkounippon21.html
2. 2) Ministry of Health: Health Japan 21 (the second term). (accessed 2021.8.21) 厚生労働省: 健康日本 21(第二次).(参照 2021.8.21) https://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_01.pdf
3. 3) World Health Organization: COVID-19. (accessed 2021.8.21) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19
4. 4) The Japanese Society of Hypertension: GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION 2019. (accessed 2021.8.21) 日本高血圧学会: 高血圧治療ガイドライン 2019. (参照 2021.8.21) https://www.jpnsh.jp/data/jsh2019/JSH2019_hp.pdf
5. 5) Dai-ichi Life Group: Survey on Changes in Life and Attitudes due to Novel Coronaviruses (Part 2). (accessed 2021.8.21) 第一生命経済研究所: 新型コロナウイルスによる生活と意識の変化に関する調査(後編). (参照 2021.8.21) http://group.dai-ichi-life.co.jp/dlri/pdf/ldi/2020/news2004_02.pdf